CERVICAL CANCER IN LOW & MIDDLE INCOME COUNTRIES
More than 80% of sexually active people encounter HPV in their lifetime, but not everyone has access to the screening that detects cervical cancer or cancerous types of HPV. Whether infrastructure or economic barriers are the issue, the result is decreased or completely eliminated screening. This means that women do not get treatment until they show more severe symptoms, often at later stages of cancer that are difficult and costly to treat.
There are numerous socioeconomic factors that contribute to the higher incidence of cervical cancer in low and middle income countries.
Having children young
Having many children
Lacking sexual/health education
High cost of healthcare/screening
Poor healthcare infrastructure
Lack of vaccination
HOW WE ARE WORKING FOR GLOBAL HEALTH
Of the 570,000 new cases of HPV induced cervical cancer annually, it is the resource-limited regions of the world which bear the brunt of the disease, and result in 90% of the cervical cancer deaths each year— a somber statistic which is predicted to rise to 98% by 2030, and the reason the first diagnostic in our pipeline will address this unmet medical need.